New Data Suggest Veracyte’s Envisia Genomic Classifier Can Help Predict Disease Progression in Interstitial Lung Disease Patients Treated with Combination Immunosuppressive Therapy

Findings presented at the European Respiratory Society International Congress 2022 SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting that the Envisia Genomic Classifier (EGC) can help predict which patients with interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), are likely to have progressive disease that declines with combination immunosuppressive … [Read more…]

Exaktera Announces Acquisition of Advanced Illumination Inc.

BOSTON–(BUSINESS WIRE)–Exaktera LLC, (“Exaktera”), a Union Park Capital (“Union Park”) portfolio company, is pleased to announce its acquisition of Advanced Illumination Inc. (“Advanced Illumination”), a long-established design and manufacturer of specialty LED lighting assemblies and drivers for machine vision, industrial imaging, bio-medical and related imaging applications. Terms of the transaction were not disclosed. Advanced Illumination’s … [Read more…]

UroGen Pharma Announces Upcoming 2022 Conferences

PRINCETON, N.J.–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will present at the following healthcare conferences in September: H.C. Wainwright & Co. Annual Global Investment Conference Tuesday, September 13 at 10:30 a.m. ET Ladenburg Thalmann Healthcare Conference … [Read more…]

CareJourney Announces Major Upgrade to its Market-leading Provider Cost and Quality Module, Now Available Through a Variety of Delivery Options

Solution offers ready-to-use, provider performance metrics that can be integrated into front-end and back-end healthcare applications to inform both critical business and clinical decisions ARLINGTON, Va.–(BUSINESS WIRE)–CareJourney, the healthcare industry’s leading source of provider cost and quality data, today announced enhancements to its provider performance module on the CareJourney platform. The module can be accessed … [Read more…]

Harris Williams Advises Jordi Labs on its Sale to RQM+

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Jordi Labs on its sale to RQM+, a portfolio company of Linden Capital Partners (Linden). Jordi Labs provides a full suite of regulatory, investigative and other related analytical chemistry testing services primarily to medical device manufacturers. The transaction was … [Read more…]

Dr. Reddy’s Laboratories Announces the Launch of Lenalidomide Capsules in the U.S. With Two of Six Strengths Eligible for First-to-market, 180-day Exclusivity

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Affordablemedicines–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch, in the U.S. market, of Lenalidomide Capsules, a therapeutic equivalent generic version of REVLIMID® (lenalidomide) Capsules approved by U.S. Food and Drug Administration … [Read more…]

Outlook on the Continuous Bioprocessing Global Market to 2027 – by Product, End-user, Application and Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Continuous Bioprocessing Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Continuous Bioprocessing Market is projected to reach USD 18,067.04 million by 2027 from USD 8,795.43 million in 2021, at a CAGR 12.74% during the forecast period. Market Statistics: The report provides market sizing and … [Read more…]

Global Chronic Pain Clinical Trial Pipeline Highlights 2022 Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Chronic Pain Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. This report provides the most up-to-date information on key pipeline products within the global Chronic Pain market. It covers emerging therapies for Chronic Pain in active clinical development stages including early and late stage clinical trials. The … [Read more…]

Neomorph, Inc. Announces Appointment of Chief Financial Officer

SAN DIEGO–(BUSINESS WIRE)–Neomorph, Inc., a venture backed biotechnology company solving critical problems in human health through the discovery and development of innovative new medicines against ‘undruggable targets,’ today announced the appointment of Bell Zhong as the company’s Chief Financial Officer. Mr. Zhong brings to Neomorph more than 17 years of investment banking and corporate finance … [Read more…]

Dialyze Direct Celebrates Its Dedicated Skilled Nursing Facility Caregivers During Nephrology Nurses Week

BROOKLYN, N.Y.–(BUSINESS WIRE)–#Dialysis–In anticipation of Nephrology Nurses Week, Dialyze Direct, the nation’s leading provider of home hemodialysis services in skilled nursing facilities (SNFs), joins the American Nephrology Nurses Association (ANNA) and its SNF partners around the country September 11-17 in honoring the dedicated and compassionate nephrology nurses who provide hemodialysis and other lifesaving services to … [Read more…]